CD40LG and COVID-19: The SARS-CoV-2-specific IgA/IgM antibodies are present only for a short period of time, whereas the SARS-CoV-2-specific IgG antibodies persist for long periods of time, thereby providing protection against SARS-CoV-2 in patients with COVID-19 [250,251].